Non-apoptotic cell death in caenorhabditis Elegans

Developmental Dynamics

Volumn 239, Issue 5, 2010, Pages 1337-1351

  Vlachos, Manolis ^a   Tavernarakis, Nektarios ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

Author keywords

Apoptosis; Caenorhabditis elegans; Dopamine; Excitotoxicity; Hypoxia; Necrosis; Neurodegeneration; Parkinson's disease; Polyglutamine proteins

Indexed keywords

ALPHA SYNUCLEIN; ION CHANNEL; LEUCINE RICH REPEAT KINASE 2; POLYGLUTAMINE; TAU PROTEIN;

APOPTOSIS; BACTERIAL INFECTION; CAENORHABDITIS ELEGANS; CELL DEATH; CELL DEGENERATION; CELL HYPOXIA; CELL TYPE; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; HISTOPATHOLOGY; HYPOOSMOTIC STRESS; MUSCLE ATROPHY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VULVA;

ANIMALS; CAENORHABDITIS ELEGANS; CELL DEATH; HUMANS; MODELS, ANIMAL;

CAENORHABDITIS ELEGANS;

EID: 77951611926     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22230     Document Type: Review

References (132)

1. Abraham MC, Lu Y, Shaham S. 2007. A morphologically conserved nonapoptotic program promotes linker cell death in Caenorhabditis elegans. Dev Cell 12: 73-86. (Pubitemid 46002599)
2. Anderson LL, Mao X, Scott BA, Crowder CM. 2009. Survival from hypoxia in C. elegans by inactivation of aminoacyl-tRNA synthetases. Science 323: 630-633.
3. Artal-Sanz M, Samara C, Syntichaki P, Tavernarakis N. 2006. Lysosomal biogenesis and function is critical for necrotic cell death in Caenorhabditis elegans. J Cell Biol 173:231-239.
4. Bano D, Dinsdale D, Cabrera-Socorro A, Maida S, Lambacher N, McColl B, Ferrando-May E, Hengartner MO, Nicotera P. 2009. Alteration of the nuclear pore complex in Ca(2+)-mediated cell death. Cell Death Differ 17:119-133.
5. Barkla DH, Gibson PR. 1999. The fate of epithelial cells in the human large intestine. Pathology 31:230-238. (Pubitemid 29417605)
6. Basnakian AG, Ueda N, Hong X, Galitovsky VE, Yin X, Shah SV. 2005. Ceramide synthase is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation. Am J Physiol Renal Physiol 288:F308-F314. (Pubitemid 40105389)
7. Bates EA, Victor M, Jones AK, Shi Y, Hart AC. 2006. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. J Neurosci 26: 2830-2838. (Pubitemid 43357867)
8. Berger AJ, Hart AC, Kaplan JM. 1998. G alphas-induced neurodegeneration in Caenorhabditis elegans. J Neurosci 18: 2871-2880.
9. Blondet B, Carpentier G, Ait-Ikhlef A, Murawsky M, Rieger F. 2002. Motoneuron morphological alterations before and after the onset of the disease in the wobbler mouse. Brain Res 930:53-57. (Pubitemid 34195628)
10. Blum ES, Driscoll M, Shaham S. 2008. Noncanonical cell death programs in the nematode Caenorhabditis elegans. Cell Death Differ 15:1124-1131. (Pubitemid 351850964)
11. Braungart E, Gerlach M, Riederer P, Baumeister R, Hoener MC. 2004. Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings. Neurodegener Dis 1: 175-183. (Pubitemid 39551794)
12. Brenner S. 1974. The genetics of Caenorhabditis elegans. Genetics 77:71-94.
13. Cao S, Gelwix CC, Caldwell KA, Caldwell GA. 2005. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J Neurosci 25:3801-3812. (Pubitemid 40570413)
14. Carre-Pierrat M, Grisoni K, Gieseler K, Mariol MC, Martin E, Jospin M, Allard B, Segalat L. 2006a. The SLO-1 BK channel of Caenorhabditis elegans is critical for muscle function and is involved in dystrophin-dependent muscle dystrophy. J Mol Biol 358: 387-395.
15. Carre-Pierrat M, Mariol MC, Chambonnier L, Laugraud A, Heskia F, Giacomotto J, Segalat L. 2006b. Blocking of striated muscle degeneration by serotonin in C. elegans. J Muscle Res Cell Motil 27:253-258. (Pubitemid 43999253)
16. Chalfie M, Wolinsky E. 1990. The identification and suppression of inherited neurodegeneration in Caenorhabditis elegans. Nature 345:410-416. (Pubitemid 20178245)
17. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A. 2004. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364:1167-1169.
18. Choi DW. 1992. Excitotoxic cell death. J Neurobiol 23:1261-1276.
19. Choi WS, Yoon SY, Oh TH, Choi EJ, O'Malley KL, Oh YJ. 1999. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J Neurosci Res 57:86-94.
20. Chu CT. 2008. Eaten alive: autophagy and neuronal cell death after hypoxia-ischemia. Am J Pathol 172:284-287.
21. Chu-Wang IW, Oppenheim RW. 1978. Cell death of motoneurons in the chick embryo spinal cord. I. A light and electron microscopic study of naturally occurring and induced cell loss during development. J Comp Neurol 177:33-57.
22. Chung S, Gumienny TL, Hengartner MO, Driscoll M. 2000. A common set of engulfment genes mediates removal of both apoptotic and necrotic cell corpses in C. elegans. Nat Cell Biol 2:931-937.
23. Clarke PG. 1990. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 181:195-213.
24. Cooper JD, Messer A, Feng AK, Chua-Couzens J, Mobley WC. 1999. Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment. J Neurosci 19:2556-2567.
25. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K, Strathearn KE, Liu F, Cao S, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD, Labaer J, Rochet JC, Bonini NM, Lindquist S. 2006. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313:324-328.
26. Dasgupta N, Patel AM, Scott BA, Crowder CM. 2007. Hypoxic preconditioning requires the apoptosis protein CED-4 in C. elegans. Curr Biol 17:1954-1959.
27. Dauer W, Przedborski S. 2003. Parkinson's disease: mechanisms and models. Neuron 39:889-909.
28. Dawson TM, Dawson VL. 2003. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822.
29. Deng X, Yin X, Allan R, Lu DD, Maurer CW, Haimovitz-Friedman A, Fuks Z, Shaham S, Kolesnick R. 2008. Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans. Science 322:110-115.
30. Driscoll M, Chalfie M. 1991. The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration. Nature 349:588-593.
31. Faber PW, Alter JR, MacDonald ME, Hart AC. 1999. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci U S A 96:179-184.
32. Faber PW, Voisine C, King DC, Bates EA, Hart AC. 2002. Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity. Proc Natl Acad Sci U S A 99:17131-17136.
33. Faleiro L, Lazebnik Y. 2000. Caspases disrupt the nuclear-cytoplasmic barrier. J Cell Biol 151:951-959.
34. Galvin BD, Kim S, Horvitz HR. 2008. Caenorhabditis elegans genes required for the engulfment of apoptotic corpses function in the cytotoxic cell deaths induced by mutations in lin-24 and lin-33. Genetics 179:403-417.
35. Gaud A, Simon JM, Witzel T, Carre-Pierrat M, Wermuth CG, Segalat L. 2004. Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans. Neuromuscul Disord 14: 365-370.
36. Giacomotto J, Pertl C, Borrel C, Walter MC, Bulst S, Johnsen B, Baillie DL, Lochmuller H, Thirion C, Segalat L. 2009. Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy. Hum Mol Genet 18:4089-4101.
37. Gidday JM. 2006. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7:437-448.
38. Gieseler K, Grisoni K, Segalat L. 2000. Genetic suppression of phenotypes arising from mutations in dystrophinrelated genes in Caenorhabditis elegans. Curr Biol 10:1092-1097.
39. Gitler AD, Bevis BJ, Shorter J, Strathearn KE, Hamamichi S, Su LJ, Caldwell KA, Caldwell GA, Rochet JC, McCaffery JM, Barlowe C, Lindquist S. 2008. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci U S A 105:145-150.
40. Group THsDCR. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971-983.
41. Gumienny TL, Lambie E, Hartwieg E, Horvitz HR, Hengartner MO. 1999. Genetic control of programmed cell death in the Caenorhabditis elegans hermaphrodite germline. Development 126:1011-1022.
42. Gustafsson AB, Gottlieb RA. 2008. Eat your heart out: role of autophagy in myocardial ischemia/reperfusion. Autophagy 4:416-421.
43. Gustin KE, Sarnow P. 2001. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J 20: 240-249. (Pubitemid 32099120)
44. Guthrie CR, Schellenberg GD, Kraemer BC. 2009. SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans. Hum Mol Genet 18:1825-1838.
45. Hall DH, Gu G, Garcia-Anoveros J, Gong L, Chalfie M, Driscoll M. 1997. Neuropathology of degenerative cell death in Caenorhabditis elegans. J Neurosci 17: 1033-1045. (Pubitemid 27043962)
46. Hamamichi S, Rivas RN, Knight AL, Cao S, Caldwell KA, Caldwell GA. 2008. Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc Natl Acad Sci U S A 105:728-733. (Pubitemid 351171776)
47. Huang M, Chalfie M. 1994. Gene interactions affecting mechanosensory transduction in Caenorhabditis elegans. Nature 367:467-470. (Pubitemid 24046049)
48. Huang L, Hanna-Rose W. 2006. EGF signaling overcomes a uterine cell death associated with temporal mis-coordination of organogenesis within the C. elegans egg-laying apparatus. Dev Biol 300:599-611. (Pubitemid 44909099)
49. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P. 1998. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705.
50. Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR, Rubinsztein DC. 2008. Huntington's disease: from pathology and genetics to potential therapies. Biochem J 412: 191-209. (Pubitemid 351758226)
51. Jeong H, Then F, Melia TJ, Jr., Mazzulli JR, Cui L, Savas JN, Voisine C, Paganetti P, Tanese N, Hart AC, Yamamoto A, Krainc D. 2009. Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 137:60-72.
52. Jia K, Hart AC, Levine B. 2007. Autophagy genes protect against disease caused by polyglutamine expansion proteins in Caenorhabditis elegans. Autophagy 3:21-25. (Pubitemid 46100705)
53. Kameyama M, Kakei M, Sato R, Shibasaki T, Matsuda H, Irisawa H. 1984. Intracellular Na+ activates a K+ channel in mammalian cardiac cells. Nature 309:354-356.
54. Kauppinen RA, Enkvist K, Holopainen I, Akerman KE. 1988a. Glucose deprivation depolarizes plasma membrane of cultured astrocytes and collapses transmembrane potassium and glutamate gradients. Neuroscience 26:283-289.
55. Kauppinen RA, McMahon HT, Nicholls DG. 1988b. Ca2+-dependent and Ca2+-independent glutamate release, energy status and cytosolic free Ca2+ concentration in isolated nerve terminals following metabolic inhibition: possible relevance to hypoglycaemia and anoxia. Neuroscience 27:175-182.
56. Kimble J, Hirsh D. 1979. The postembryonic cell lineages of the hermaphrodite and male gonads in Caenorhabditis elegans. Dev Biol 70:396-417. (Pubitemid 10223307)
57. Korswagen HC, Park JH, Ohshima Y, Plasterk RH. 1997. An activating mutation in a Caenorhabditis elegans Gs protein induces neural degeneration. Genes Dev 11:1493-1503. (Pubitemid 27274395)
58. Korswagen HC, van der Linden AM, Plasterk RH. 1998. G protein hyperactivation of the Caenorhabditis elegans adenylyl cyclase SGS-1 induces neuronal degeneration. Embo J 17: 5059-5065.
59. Koumenis C, Bi M, Ye J, Feldman D, Koong AC. 2007. Hypoxia and the unfolded protein response. Methods Enzymol 435:275-293.
60. Kraemer BC, Schellenberg GD. 2007. SUT-1 enables tau-induced neurotoxicity in C. elegans. Hum Mol Genet 16: 1959-1971.
61. Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, Schellenberg GD. 2003. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci U S A 100: 9980-9985. (Pubitemid 37087054)
62. Kraemer BC, Burgess JK, Chen JH, Thomas JH, Schellenberg GD. 2006. Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. Hum Mol Genet 15: 1483-1496.
63. Kumar A, Rothman JH. 2007. Cell death: hook, line and linker. Curr Biol 17: R286-R289. (Pubitemid 46552240)
64. Kuwahara T, Koyama A, Gengyo-Ando K, Masuda M, Kowa H, Tsunoda M, Mitani S, Iwatsubo T. 2006. Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans. J Biol Chem 281:334-340. (Pubitemid 43671193)
65. Lakso M, Vartiainen S, Moilanen AM, Sirvio J, Thomas JH, Nass R, Blakely RD, Wong G. 2003. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J Neurochem 86: 165-172. (Pubitemid 36753857)
66. Lee JM, Zipfel GJ, Choi DW. 1999. The changing landscape of ischaemic brain injury mechanisms. Nature 399:A7-A14. (Pubitemid 29295654)
67. Lee VM, Goedert M, Trojanowski JQ. 2001. Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121-1159.
68. Lettre G, Hengartner MO. 2006. Developmental apoptosis in C. elegans: a complex CEDnario. Nat Rev Mol Cell Biol 7:97-108. (Pubitemid 43278293)
69. Locke CJ, Fox SA, Caldwell GA, Caldwell KA. 2008. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease. Neurosci Lett 439:129-133.
70. Luke CJ, Pak SC, Askew YS, Naviglia TL, Askew DJ, Nobar SM, Vetica AC, Long OS, Watkins SC, Stolz DB, Barstead RJ, Moulder GL, Bromme D, Silverman GA. 2007. An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury. Cell 130:1108-1119.
71. Mabon ME, Mao X, Jiao Y, Scott BA, Crowder CM. 2009. Systematic identification of gene activities promoting hypoxic death. Genetics 181:483-496.
72. Magni G, Amici A, Emanuelli M, Raffaelli N, Ruggieri S. 1999. Enzymology of NAD+ synthesis. Adv Enzymol Relat Areas Mol Biol 73:135-182, xi.
73. Maharaj DS, Saravanan KS, Maharaj H, Mohanakumar KP, Daya S. 2004. Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. Neurochem Int 44:355-360. (Pubitemid 37485867)
74. Mano I, Driscoll M. 2009. Caenorhabditis elegans glutamate transporter deletion induces AMPA-receptor/adenylyl cyclase 9-dependent excitotoxicity. J Neurochem 108:1373-1384.
75. Mariol MC, Segalat L. 2001. Muscular degeneration in the absence of dystrophin is a calcium-dependent process. Curr Biol 11:1691-1694. (Pubitemid 33037781)
76. Mariol MC, Martin E, Chambonnier L, Segalat L. 2007. Dystrophin-dependent muscle degeneration requires a fully functional contractile machinery to occur in C. elegans. Neuromuscul Disord 17:56-60. (Pubitemid 46186006)
77. Marvanova M, Nichols CD. 2007. Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA. J Mol Neurosci 31:127-137. (Pubitemid 46742296)
78. Mayhew TM, Myklebust R, Whybrow A, Jenkins R. 1999. Epithelial integrity, cell death and cell loss in mammalian small intestine. Histol Histopathol 14: 257-267.
79. Mendenhall AR, LaRue B, Padilla PA. 2006. Glyceraldehyde-3-phosphate dehydrogenase mediates anoxia response and survival in Caenorhabditis elegans. Genetics 174:1173-1187. (Pubitemid 44808291)
80. Menuz V, Howell KS, Gentina S, Epstein S, Riezman I, Fornallaz-Mulhauser M, Hengartner MO, Gomez M, Riezman H, Martinou JC. 2009. Protection of C. elegans from anoxia by HYL-2 ceramide synthase. Science 324:381-384.
81. Miyasaka T, Ding Z, Gengyo-Ando K, Oue M, Yamaguchi H, Mitani S, Ihara Y. 2005. Progressive neurodegeneration in C. elegans model of tauopathy. Neurobiol Dis 20:372-383. (Pubitemid 41476263)
82. Moerman FA. 1996. Muscle: structure, function, development. In: Riddle BT, Meyer B, Priess J, editors. The nematode C. elegans II. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. p 417-470.
83. Murdoch WJ, Wilken C, Young DA. 1999. Sequence of apoptosis and inflammatory necrosis within the formative ovulatory site of sheep follicles. J Reprod Fertil 117:325-329.
84. Nass R, Hall DH, Miller DM, 3rd, Blakely RD. 2002. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad Sci U S A 99:3264-3269.
85. Neuwald AF, Aravind L, Spouge JL, Koonin EV. 1999. AAA+: a class of chaper-one-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res 9: 27-43. (Pubitemid 29095146)
86. Nicotera P, Leist M, Manzo L. 1999. Neuronal cell death: a demise with different shapes. Trends Pharmacol Sci 20:46-51. (Pubitemid 29322309)
87. Novgorodov SA, Gudz TI. 2009. Ceramide and mitochondria in ischemia/reperfusion. J Cardiovasc Pharmacol 53: 198-208.
88. Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, Dawson TM, Ross CA. 2001. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291: 2423-2428.
89. Nyamsuren O, Faggionato D, Loch W, Schulze E, Baumeister R. 2007. A mutation in CHN-1/CHIP suppresses muscle degeneration in Caenorhabditis elegans. Dev Biol 312:193-202.
90. Pewzner-Jung Y, Ben-Dor S, Futerman AH. 2006. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: insights into the regulation of ceramide synthesis. J Biol Chem 281:25001-25005.
91. Pilar G, Landmesser L. 1976. Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia. J Cell Biol 68: 339-356.
92. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
93. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD. 1998. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43:815-825.
94. Pu P, Le W. 2008. Dopamine neuron degeneration induced by MPP+ is independent of CED-4 pathway in Caenorhabditis elegans. Cell Res 18:978-981.
95. Qiao L, Hamamichi S, Caldwell KA, Caldwell GA, Yacoubian TA, Wilson S, Xie ZL, Speake LD, Parks R, Crabtree D, Liang Q, Crimmins S, Schneider L, Uchiyama Y, Iwatsubo T, Zhou Y, Peng L, Lu Y, Standaert DG, Walls KC, Shacka JJ, Roth KA, Zhang J. 2008. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol Brain 1:17.
96. Roach HI, Clarke NM. 2000. Physiological cell death of chondrocytes in vivo is not confined to apoptosis. New observations on the mammalian growth plate. J Bone Joint Surg Br 82:601-613.
97. Saha S, Guillily MD, Ferree A, Lanceta J, Chan D, Ghosh J, Hsu CH, Segal L, Raghavan K, Matsumoto K, Hisamoto N, Kuwahara T, Iwatsubo T, Moore L, Goldstein L, Cookson M, Wolozin B. 2009. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J Neurosci 29: 9210-9218.
98. Samara C, Syntichaki P, Tavernarakis N. 2008. Autophagy is required for necrotic cell death in Caenorhabditis elegans. Cell Death Differ 15:105-112.
99. Samokhvalov V, Scott BA, Crowder CM. 2008. Autophagy protects against hypoxic injury in C. elegans. Autophagy 4:1034-1041.
100. Schapira AH. 2008. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7:97-109.
101. Scott BA, Avidan MS, Crowder CM. 2002. Regulation of hypoxic death in C. elegans by the insulin/IGF receptor homolog DAF-2. Science 296:2388-2391.
102. Shashidharan P, Good PF, Hsu A, Perl DP, Brin MF, Olanow CW. 2000. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease. Brain Res 877:379-381.
103. Shreffler W, Magardino T, Shekdar K, Wolinsky E. 1995. The unc-8 and sup-40 genes regulate ion channel function in Caenorhabditis elegans motor neurons. Genetics 139:1261-1272.
104. Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PG, Irving JA, Lomas DA, Luke CJ, Moyer RW, Pemberton PA, Remold-O'Donnell E, Salvesen GS, Travis J, Whisstock JC. 2001. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 276:33293-33296.
105. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K. 2003. alpha-Synuclein locus triplication causes Parkinson's disease. Science 302:841.
106. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. 1997. Alpha-synuclein in Lewy bodies. Nature 388:839-840.
107. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. 1998. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 95:7737-7741.
108. Sulston JE, Horvitz HR. 1977. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 56: 110-156.
109. Sulston JE, Albertson DG, Thomson JN. 1980. The Caenorhabditis elegans male: postembryonic development of nongonadal structures. Dev Biol 78:542-576.
110. Sulston JE, Schierenberg E, White JG, Thomson JN. 1983. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol 100:64-119.
111. Syntichaki P, Tavernarakis N. 2002. Death by necrosis. Uncontrollable catastrophe, or is there order behind the chaos? EMBO Rep 3:604-609.
112. Syntichaki P, Tavernarakis N. 2003. The biochemistry of neuronal necrosis: rogue biology? Nat Rev Neurosci 4:672-684.
113. Syntichaki P, Tavernarakis N. 2004. Genetic models of mechanotransduction: the nematode Caenorhabditis elegans. Physiol Rev 84:1097-1153.
114. Syntichaki P, Xu K, Driscoll M, Tavernarakis N. 2002. Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 419:939-944.
115. Syntichaki P, Samara C, Tavernarakis N. 2005. The vacuolar H+ -ATPase mediates intracellular acidification required for neurodegeneration in C. elegans. Curr Biol 15:1249-1254.
116. Tavernarakis N, Shreffler W, Wang S, Driscoll M. 1997. unc-8, a DEG/ENaC family member, encodes a subunit of a candidate mechanically gated channel that modulates C. elegans locomotion. Neuron 18:107-119.
117. Toth ML, Simon P, Kovacs AL, Vellai T. 2007. Influence of autophagy genes on ion-channel-dependent neuronal degeneration in Caenorhabditis elegans. J Cell Sci 120:1134-1141. (Pubitemid 46638525)
118. Treinin M, Chalfie M. 1995. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron 14:871-877.
119. van der Horst A, Schavemaker JM, Pellisvan Berkel W, Burgering BM. 2007. The Caenorhabditis elegans nicotinamidase PNC-1 enhances survival. Mech Ageing Dev 128:346-349.
120. Vellai T, Toth ML, Kovacs AL. 2007. Janus-faced autophagy: a dual role of cellular self-eating in neurodegeneration? Autophagy 3:461-463.
121. Voisine C, Varma H, Walker N, Bates EA, Stockwell BR, Hart AC. 2007. Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans. PLoS One 2:e504.
122. Vrablik TL, Huang L, Lange SE, Hanna-Rose W. 2009. Nicotinamidase modulation of NAD+ biosynthesis and nicotinamide levels separately affect reproductive development and cell survival in C. elegans. Development 136:3637-3646.
123. Walker NI, Harmon BV, Gobe GC, Kerr JF. 1988. Patterns of cell death. Methods Achiev Exp Pathol 13:18-54.
124. Weidhaas JB, Eisenmann DM, Holub JM, Nallur SV. 2006a. A Caenorhabditis elegans tissue model of radiation-induced reproductive cell death. Proc Natl Acad Sci U S A 103:9946-9951. (Pubitemid 43993603)
125. Weidhaas JB, Eisenmann DM, Holub JM, Nallur SV. 2006b. A conserved RAS/mitogen-activated protein kinase pathway regulates DNA damage-induced cell death postirradiation in Radelegans. Cancer Res 66:10434-10438.
126. Wong D, Bazopoulou D, Pujol N, Tavernarakis N, Ewbank JJ. 2007. Genome-wide investigation reveals pathogen-specific and shared signatures in the response of Caenorhabditis elegans to infection. Genome Biol 8:R194. (Pubitemid 351895471)
127. Xu K, Tavernarakis N, Driscoll M. 2001. Necrotic cell death in C. elegans requires the function of calreticulin and regulators of Ca(2+) release from the endoplasmic reticulum. Neuron 31: 957-971. (Pubitemid 32925282)
128. Yamashima T. 2000. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62: 273-295. (Pubitemid 30326777)
129. Yamashima T. 2004. Ca2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates. Cell Calcium 36:285-293.
130. Yuan A, Dourado M, Butler A, Walton N, Wei A, Salkoff L. 2000. SLO-2, a K+ channel with an unusual Cl-dependence. Nat Neurosci 3:771-779.
131. Yuan A, Santi CM, Wei A, Wang ZW, Pollak K, Nonet M, Kaczmarek L, Crowder CM, Salkoff L. 2003. The sodium-activated potassium channel is encoded by a member of the Slo gene family. Neuron 37:765-773. (Pubitemid 36288549)
132. Zoghbi HY, Orr HT. 2000. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23:217-247.